IP Library Granted Patent US 9,670,514
Granted Patent B2
US 9,670,514 · App. 14/123,291 · Granted Jun 6, 2017

Method for producing polysaccharide

Inventors: Fusamitsu Yanagihara (Kyoto, JP); Kentaro Matsuo (Kyoto, JP); Miki Kusano (Kyoto, JP)
Assignee: SANYO CHEMICAL INDUSTRIES, LTD.
C12P19/04C12P19/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,670,514
App. No.
14/123,291
Granted
Jun 6, 2017
Kind
B2
Abstract

The present invention aims to provide a method for producing a polysaccharide with high efficiency using a polysaccharide synthase. The present invention provides a method for producing a polysaccharide, including allowing polysaccharide synthase (B) to act on ribonucleoside diphosphate-monosaccharide (A) to produce a polysaccharide, wherein in 10 to 100% of the duration in which (B) acts on (A), the concentration of ribonucleoside diphosphate in a reaction solution is lower than 100 times an inhibitory concentration IC 50 against polysaccharide synthase (B).

Claims (22)

1. A method for producing a hyaluronan,

wherein steps (1) to (3) described below are simultaneously performed:

Step (1): producing a hyaluronan and a uridine diphosphate by allowing a hyaluronan synthase (B-1) to act on a uridine diphosphate-glucuronic acid and a uridine diphosphate-N-acetylglucosamine;

Step (2): producing a uridine triphosphate by allowing a uridine triphosphate synthase (D4-1) to act on the uridine diphosphate and a phosphate-containing compound (F); and

Step (3): producing a uridine diphosphate-glucuronic acid by allowing a uridine triphosphate-monosaccharide-1-phosphate uridylyltransferase (G) to act on the uridine triphosphate and a 1-phospho-glucuronic acid,

wherein initial concentrations of the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine are 0.1 mM to 2M, initial concentration of hyaluronan synthase (B-1) is 0.1 to 100,000 U/L,

wherein 1 U of hyaluronan synthase (B-1) represents the amount of enzyme to produce the hyaluronan and the uridine diphosphate from 1 μmol of the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine per minute at 30° C. and pH of 7.0,

wherein a duration in which the hyaluronan synthase (B-1) acts on the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine is 10 minute or more,

wherein in 10 to 100% of the duration, the concentration of the uridine diphosphate in the reaction solution is lower than 100 times an inhibitory concentration IC 50 against the hyaluronan synthase (B-1), and

wherein the inhibitory concentration IC 50 refers to a concentration of the uridine diphosphate at which an enzyme activity of the hyaluronan synthase (B-1) is reduced by half under a condition where the hyaluronan synthase (B-1) has a concentration at which the hyaluronan synthase (B-1) acts on the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine, wherein the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine are used as a substrate and the uridine diphosphate is used as an inhibitor, and

wherein the phosphate-containing compound (F) is at least one compound selected from the group consisting of triaminophosphine oxide, ω-phosphono-L-arginine, polyphosphoric acid, phosphoenolpyruvic acid and salts thereof, carbamoyl phosphate, 1,3-Bisphosphoglycerate, phosphocreatine, and nucleoside triphosphate.

2. The method for producing a hyaluronan according to claim 1 ,

wherein an enzyme activity ratio (Y 1 ) calculated from formula (1) is not lower than 0.1,

enzyme activity ratio ( Y 1 )= V max 1 /V max 2   (1),

wherein Vmax 1 is the enzyme activity of the uridine triphosphate synthase (D4-1) on the uridine diphosphate, and Vmax 2 is the enzyme activity of the uridine triphosphate synthase (D4-1) on the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetvlglucosamine.

3. The method for producing a hyaluronan according to claim 1 ,

wherein an enzyme activity ratio (Y 2 ) calculated from formula (2) is not lower than 0.1,

enzyme activity ratio ( Y 2 )= V max 1 /V max 3   (2),

where Vmax 1 is the enzyme activity of the uridine triphosphate synthase (D4-1) on the uridine diphosphate, and Vmax 3 is the enzyme activity of the hyaluronan synthase (B-1) on the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine.

4. The method for producing a hyaluronan according to claim 1 , wherein a Michaelis constant Km is lower than 100 times the inhibitory concentration IC 50 ,

wherein the Michaelis constant Km refers to a Michaelis constant of reaction to synthesize the uridine triphosphate in the presence of the phosphate-containing compound (F), the using uridine diphosphate as a substrate and the uridine triphosphate synthase as an enzyme, and

wherein the inhibitory concentration IC 50 refers to a concentration of the uridine diphosphate at which an enzyme activity of the hyaluronan synthase (B-1) is reduced by half under a condition where the hyaluronan synthase (B-1) has a concentration at which the hyaluronan synthase (B-1) acts on the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine, wherein the uridine diphosphate-glucuronic acid and the uridine diphosphate-N-acetylglucosamine are used as substrates and the uridine diphosphate is used as an inhibitor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2014
From: YANAGIHARA, FUSAMITSU; MATSUO, KENTARO; KUSANO, MIKI
To: SANYO CHEMICAL INDUSTRIES, LTD.
Reel/Frame 032078/0530 →
Priority Claims (4)
JP 2011-128778 · Jun 9, 2011 · national
JP 2011-158077 · Jul 19, 2011 · national
JP 2011-195239 · Sep 7, 2011 · national
JP 2011-197796 · Sep 12, 2011 · national
Continuity (1)
Related Publication 20140134679A1 · May 15, 2014